Cell-penetrating peptides for drug delivery across membrane barriers

被引:177
作者
Foged, Camilla [1 ]
Nielsen, Hanne Moerck [1 ]
机构
[1] Univ Copenhagen, Dept Pharmaceut & Analyt Chem, DK-2100 Copenhagen O, Denmark
关键词
biomacromolecule; cell-penetrating peptides; colloidal carriers; drug delivery; endocytosis; intracellular delivery; nucleic acid; peptide; protein; transduction; translocation;
D O I
10.1517/17425247.5.1.105
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
During the last decade, cell-penetrating peptides have been investigated for their ability to overcome the plasma membrane barrier of mammalian cells for the intracellular or transcellular delivery of cargoes as diverse as low molecular weight drugs, imaging agents, oligonucleotides, peptides, proteins and colloidal carriers such as liposomes and polymeric nanoparticles. Their ability to cross biological membranes in a non-disruptive way without apparent toxicity is highly desired for increasing drug bioavailability. This review provides an overview of the application of cell-penetrating peptides as transmembrane drug delivery agents, according to the recent literature, and discusses critical issues and future challenges in relation to fully understanding the fundamental principles of the cell-penetrating peptide-mediated membrane translocation of cargoes and the exploitation of their therapeutic potential.
引用
收藏
页码:105 / 117
页数:13
相关论文
共 103 条
[31]   Design, synthesis, and characterization of pH-sensitive PEG-PE conjugates for stimuli-sensitive pharmaceutical nanocarriers: The effect of substitutes at the hydrazone linkage on the pH stability of PEG-PE conjugates [J].
Kale, Amit A. ;
Torchilin, Vladimir P. .
BIOCONJUGATE CHEMISTRY, 2007, 18 (02) :363-370
[32]   Evaluation. of transportan 10 in PEI mediated plasmid delivery assay [J].
Kilk, K ;
El-Andaloussi, S ;
Järver, P ;
Meikas, A ;
Valkna, A ;
Bartfai, T ;
Kogerman, P ;
Metsis, M ;
Langel, Ü .
JOURNAL OF CONTROLLED RELEASE, 2005, 103 (02) :511-523
[33]   Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI [J].
Kleemann, E ;
Neu, M ;
Jekel, N ;
Fink, L ;
Schmehl, T ;
Gessler, T ;
Seeger, W ;
Kissel, T .
JOURNAL OF CONTROLLED RELEASE, 2005, 109 (1-3) :299-316
[34]   Transport of surface-modified nanoparticles through cell monolayers [J].
Koch, AM ;
Reynolds, F ;
Merkle, HR ;
Weissleder, R ;
Josephson, L .
CHEMBIOCHEM, 2005, 6 (02) :337-345
[35]   No entry for TAT(44-57) into liposomes and intact MDCK cells:: novel approach to study membrane permeation of cell-penetrating peptides [J].
Krämer, SD ;
Wunderli-Allenspach, H .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2003, 1609 (02) :161-169
[36]  
Lagerholm B Christoffer, 2007, Methods Mol Biol, V374, P105
[37]   Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells [J].
Lewin, M ;
Carlesso, N ;
Tung, CH ;
Tang, XW ;
Cory, D ;
Scadden, DT ;
Weissleder, R .
NATURE BIOTECHNOLOGY, 2000, 18 (04) :410-414
[38]   Insulin-cell penetrating peptide hybrids with improved intestinal absorption efficiency [J].
Liang, JF ;
Yang, VC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 335 (03) :734-738
[39]   Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide [J].
Lindgren, M ;
Rosenthal-Aizman, K ;
Saar, K ;
Eiríksdóttir, E ;
Jiang, Y ;
Sassian, M ;
Östlund, P ;
Hällbrink, M ;
Langel, Ü .
BIOCHEMICAL PHARMACOLOGY, 2006, 71 (04) :416-425
[40]   Passage of cell-penetrating peptides across a human epithelial cell layer in vitro [J].
Lindgren, ME ;
Hällbrink, MM ;
Elmquist, AM ;
Langel, Ü .
BIOCHEMICAL JOURNAL, 2004, 377 :69-76